{"id":"https://genegraph.clinicalgenome.org/r/1c738f37-2c01-48ed-afd5-1402d20be9fav1.0","type":"EvidenceStrengthAssertion","dc:description":"There has been sufficient amount of evidence published associating the FLCN gene with Birt-Hogg-Dube syndrome (BHD) since the gene-disease relationship was first proposed by Nickerson et al. (2002). Plenty of case level studies have been performed with BHD patients that have variants in the FLCN gene. FCLN, which is expressed in skin, lung, and kidney, acts as a general tumor suppressor in human RCC cells in vivo. Knockdown of FLCN in ACHN cells led to the formation of significantly larger tumors and reintroduction of FLCN in 786-0 cells led to a strong decrease in tumor growth. Flcn+/- mice display preneoplastic kidney lesions and tumors and a Nihon rat model of inherited renal cancer with an intragenic Flcn mutation was also established. All of these evidences suggest a definitive relationship between the FLCN gene and Birt-Hogg-Dube syndrome (BHD).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/1c738f37-2c01-48ed-afd5-1402d20be9fa","GCISnapshot":"https://genegraph.clinicalgenome.org/r/c96620e8-f9c9-41a0-a979-31fb9928abb6","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/c96620e8-f9c9-41a0-a979-31fb9928abb6_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10023","date":"2020-09-01T00:00:00Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/c96620e8-f9c9-41a0-a979-31fb9928abb6_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10023","date":"2019-04-19T16:00:00.000Z","role":"Approver"}],"curationReasonDescription":"The segregation score should be 1.5 for candidate gene sequencing, but it doesn't change the total score.","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c96620e8-f9c9-41a0-a979-31fb9928abb6_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c96620e8-f9c9-41a0-a979-31fb9928abb6_ad_null_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/01edb7d4-92e7-46b7-9745-80c174b73c99_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7057e09e-6c7b-4cb6-80b1-6c29d5821058","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12204536","rdfs:label":"Family 210","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"Sequence analysis of the 14 coding exons contained in two mRNAs (BC015725 and BC015687).","firstTestingMethod":"PCR","phenotypeFreeText":"ORPHA:122, BIRT-HOGG-DUBÉ SYNDROME","phenotypes":["obo:HP_0002108","obo:HP_0009726","obo:HP_0030436"],"previousTesting":true,"previousTestingDescription":"Linkage analysis in 9 BHD families and localized the BHD disease locus to a 4 cM region of chromosome 17p11.2 between D17S1857 and D17S805 (Schmidt etal., 2001).","secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/01edb7d4-92e7-46b7-9745-80c174b73c99_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12204536","allele":{"id":"https://genegraph.clinicalgenome.org/r/0973bb5e-4bb1-4b10-8231-eb4892c70447","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_144997.6(FLCN):c.1285dup (p.His429Profs)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/3363"}}}}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/191d9e1b-4136-4b02-b8a9-e50003210864_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dbc07d06-bb44-4cfa-a57b-80f8f54bd7af","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12204536","rdfs:label":"Family 230","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"Sequence analysis of the 14 coding exons contained in two mRNAs (BC015725 and BC015687).","firstTestingMethod":"PCR","phenotypeFreeText":"ORPHA:122, BIRT-HOGG-DUBÉ SYNDROME","phenotypes":["obo:HP_0009726","obo:HP_0030436","obo:HP_0002108"],"previousTesting":true,"previousTestingDescription":"Linkage analysis in 9 BHD families and localized the BHD disease locus to a 4 cM region of chromosome 17p11.2 between D17S1857 and D17S805 (Schmidt etal., 2001).","secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/191d9e1b-4136-4b02-b8a9-e50003210864_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12204536","allele":{"id":"https://genegraph.clinicalgenome.org/r/6ae4b030-612c-46c2-97a9-8cc62f17936e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_144997.6(FLCN):c.1389C>G (p.Tyr463Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/3367"}}}}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/899ad185-5e28-442b-9602-e447290769ab_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a54b6a52-c581-461e-898d-b81f090309fe","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12204536","rdfs:label":"Family 201","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"Sequence analysis of the 14 coding exons contained in two mRNAs (BC015725 and BC015687).","firstTestingMethod":"PCR","phenotypeFreeText":"ORPHA:122, BIRT-HOGG-DUBÉ SYNDROME","phenotypes":["obo:HP_0030436","obo:HP_0009726","obo:HP_0002108"],"previousTesting":true,"previousTestingDescription":"Linkage analysis in 9 BHD families and localized the BHD disease locus to a 4 cM region of chromosome 17p11.2 between D17S1857 and D17S805 (Schmidt etal., 2001).","secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/899ad185-5e28-442b-9602-e447290769ab_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12204536","allele":{"id":"https://genegraph.clinicalgenome.org/r/42203493-1ac9-4619-94bc-3fa7461ff219","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_144997.6(FLCN):c.1285delC (p.His429Thrfs)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/3364"}}}}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/427c52da-5d03-48e4-8009-73f8af84b982_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5b040d71-09ec-49f8-ae5c-1da82ac0638b","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12204536","rdfs:label":"Family 228","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"Sequence analysis of the 14 coding exons contained in two mRNAs (BC015725 and BC015687).","firstTestingMethod":"PCR","phenotypeFreeText":"ORPHA:122, BIRT-HOGG-DUBÉ SYNDROME","phenotypes":["obo:HP_0030436","obo:HP_0009726","obo:HP_0002108"],"previousTesting":true,"previousTestingDescription":"Linkage analysis in 9 BHD families and localized the BHD disease locus to a 4 cM region of chromosome 17p11.2 between D17S1857 and D17S805 (Schmidt etal., 2001).","secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/427c52da-5d03-48e4-8009-73f8af84b982_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12204536","allele":{"id":"https://genegraph.clinicalgenome.org/r/de5f0eb6-0402-469a-95d1-2c27e6f0d10c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_144997.6(FLCN):c.927_954dup (p.Gly319Serfs)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/96493"}}}}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/52a96e3b-0fb2-47f9-ae3b-8bf6c36e8edd_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9db49e35-6700-42b5-9d84-5cff2d193640","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12204536","rdfs:label":"Family 200","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"Sequence analysis of the 14 coding exons contained in two mRNAs (BC015725 and BC015687).","firstTestingMethod":"PCR","phenotypeFreeText":"ORPHA:122, BIRT-HOGG-DUBÉ SYNDROME","phenotypes":["obo:HP_0030436","obo:HP_0009726","obo:HP_0002108"],"previousTesting":true,"previousTestingDescription":"Linkage analysis in 9 BHD families and localized the BHD disease locus to a 4 cM region of chromosome 17p11.2 between D17S1857 and D17S805 (Schmidt etal., 2001).","secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/52a96e3b-0fb2-47f9-ae3b-8bf6c36e8edd_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12204536","allele":{"id":"https://genegraph.clinicalgenome.org/r/0973bb5e-4bb1-4b10-8231-eb4892c70447"}}}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/ba88be34-2e9e-464b-97f7-808d89b4dd30_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/404117f9-9be0-4b6f-b5fb-cefc113d0d43","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12204536","rdfs:label":"Family 174","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"Sequence analysis of the 14 coding exons contained in two mRNAs (BC015725 and BC015687).","firstTestingMethod":"PCR","phenotypeFreeText":"ORPHA:122, BIRT-HOGG-DUBÉ SYNDROME","phenotypes":["obo:HP_0009726","obo:HP_0030436","obo:HP_0002108"],"previousTesting":true,"previousTestingDescription":"Linkage analysis in 9 BHD families and localized the BHD disease locus to a 4 cM region of chromosome 17p11.2 between D17S1857 and D17S805 (Schmidt etal., 2001).","secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/ba88be34-2e9e-464b-97f7-808d89b4dd30_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12204536","allele":{"id":"https://genegraph.clinicalgenome.org/r/0973bb5e-4bb1-4b10-8231-eb4892c70447"}}}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/12dd8bec-6404-4b03-a077-9aa270817c87_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/79da4c79-3e8a-4812-87ea-cf1ad58ea149","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12204536","rdfs:label":"Family 202","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"Sequence analysis of the 14 coding exons contained in two mRNAs (BC015725 and BC015687).","firstTestingMethod":"PCR","phenotypeFreeText":"ORPHA:122, BIRT-HOGG-DUBÉ SYNDROME","phenotypes":["obo:HP_0002108","obo:HP_0030436","obo:HP_0009726"],"previousTesting":true,"previousTestingDescription":"Linkage analysis in 9 BHD families and localized the BHD disease locus to a 4 cM region of chromosome 17p11.2 between D17S1857 and D17S805 (Schmidt etal., 2001).","secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/12dd8bec-6404-4b03-a077-9aa270817c87_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12204536","allele":{"id":"https://genegraph.clinicalgenome.org/r/0646e7b4-0500-4b96-a596-c4f570ec27c4","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_144997.5(FLCN):c.632_633delAGinsC (p.Glu211Alafs)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/253231"}}}}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/db496611-be5f-44c5-8051-03f9e0a21377_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7f70d91a-529c-4d37-a93b-10e3204a785e","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12204536","rdfs:label":"Family 216","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"Sequence analysis of the 14 coding exons contained in two mRNAs (BC015725 and BC015687).","firstTestingMethod":"PCR","phenotypeFreeText":"ORPHA:122, BIRT-HOGG-DUBÉ SYNDROME","phenotypes":["obo:HP_0002108","obo:HP_0030436","obo:HP_0009726"],"previousTesting":true,"previousTestingDescription":"Linkage analysis in 9 BHD families and localized the BHD disease locus to a 4 cM region of chromosome 17p11.2 between D17S1857 and D17S805 (Schmidt etal., 2001).","secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/db496611-be5f-44c5-8051-03f9e0a21377_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12204536","allele":{"id":"https://genegraph.clinicalgenome.org/r/0973bb5e-4bb1-4b10-8231-eb4892c70447"}}}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityOverallAutosomalDominantNullVariantEvidenceCriteria","strengthScore":10},{"id":"https://genegraph.clinicalgenome.org/r/c96620e8-f9c9-41a0-a979-31fb9928abb6_ad_other_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f591b130-88c6-4d1e-bb90-6f321d74a89d_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Disrupt protein stability (PMID: 21538689, Figure 4)","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/acab4406-6303-483d-a00a-5a42e4272c0d","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19659657","rdfs:label":"51","ageType":"AgeAtReport","ageUnit":"Years","ageValue":57,"detectionMethod":"Blood DNA analysis","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"PCR","phenotypeFreeText":"ORPHA:122, BIRT-HOGG-DUBÉ SYNDROME","phenotypes":["obo:HP_0030436","obo:HP_0002108"],"previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/f591b130-88c6-4d1e-bb90-6f321d74a89d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19659657","allele":{"id":"https://genegraph.clinicalgenome.org/r/5e85525c-3142-44d3-a2f1-a9912378e91e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_144997.5(FLCN):c.1522_1524delAAG (p.Lys508del)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/96477"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallAutosomalDominantOtherVariantEvidenceCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/c96620e8-f9c9-41a0-a979-31fb9928abb6_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fb60290e-4388-4436-8c07-fe3101ed49ab_proband_segregation","type":"FamilyCosegregation","dc:description":"Only three family members are sequenced","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19659657","rdfs:label":"Chinese family","estimatedLodScore":2.41,"family":{"id":"https://genegraph.clinicalgenome.org/r/fb60290e-4388-4436-8c07-fe3101ed49ab","type":"Family","rdfs:label":"Chinese family","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/acab4406-6303-483d-a00a-5a42e4272c0d"}},"meetsInclusionCriteria":false,"phenotypeFreeText":"ORPHA:122, BIRT-HOGG-DUBÉ SYNDROME","phenotypePositiveAllelePositive":8,"phenotypes":["obo:HP_0002108","obo:HP_0030436"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/acab4406-6303-483d-a00a-5a42e4272c0d"}},{"id":"https://genegraph.clinicalgenome.org/r/73ee960b-5136-44e8-abe0-8868b0beb6eb_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12204536","rdfs:label":"Family 174","family":{"id":"https://genegraph.clinicalgenome.org/r/73ee960b-5136-44e8-abe0-8868b0beb6eb","type":"Family","rdfs:label":"Family 174","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"},"member":{"id":"https://genegraph.clinicalgenome.org/r/404117f9-9be0-4b6f-b5fb-cefc113d0d43"}},"phenotypeFreeText":"ORPHA:122, BIRT-HOGG-DUBÉ SYNDROME","phenotypePositiveAllelePositive":1,"phenotypes":["obo:HP_0002108","obo:HP_0009726","obo:HP_0030436"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/404117f9-9be0-4b6f-b5fb-cefc113d0d43"}},{"id":"https://genegraph.clinicalgenome.org/r/074a4174-9b4f-49ea-8862-5d6997a74a06_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12204536","rdfs:label":"Family 216","family":{"id":"https://genegraph.clinicalgenome.org/r/074a4174-9b4f-49ea-8862-5d6997a74a06","type":"Family","rdfs:label":"Family 216","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"},"member":{"id":"https://genegraph.clinicalgenome.org/r/7f70d91a-529c-4d37-a93b-10e3204a785e"}},"phenotypeFreeText":"ORPHA:122, BIRT-HOGG-DUBÉ SYNDROME","phenotypePositiveAllelePositive":1,"phenotypes":["obo:HP_0002108","obo:HP_0030436","obo:HP_0009726"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/7f70d91a-529c-4d37-a93b-10e3204a785e"}},{"id":"https://genegraph.clinicalgenome.org/r/52f59820-6ec9-4a4a-b893-6ac039f5cdce_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12204536","rdfs:label":"Family 200","estimatedLodScore":0.9,"family":{"id":"https://genegraph.clinicalgenome.org/r/52f59820-6ec9-4a4a-b893-6ac039f5cdce","type":"Family","rdfs:label":"Family 200","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"},"member":{"id":"https://genegraph.clinicalgenome.org/r/9db49e35-6700-42b5-9d84-5cff2d193640"}},"meetsInclusionCriteria":false,"phenotypeFreeText":"ORPHA:122, BIRT-HOGG-DUBÉ SYNDROME","phenotypePositiveAllelePositive":4,"phenotypes":["obo:HP_0030436","obo:HP_0009726","obo:HP_0002108"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/9db49e35-6700-42b5-9d84-5cff2d193640"}},{"id":"https://genegraph.clinicalgenome.org/r/51e117f1-c7f9-4878-b1dd-6f73586eef47_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12204536","rdfs:label":"Family 228","estimatedLodScore":2.11,"family":{"id":"https://genegraph.clinicalgenome.org/r/51e117f1-c7f9-4878-b1dd-6f73586eef47","type":"Family","rdfs:label":"Family 228","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"},"member":{"id":"https://genegraph.clinicalgenome.org/r/5b040d71-09ec-49f8-ae5c-1da82ac0638b"}},"meetsInclusionCriteria":true,"phenotypeFreeText":"ORPHA:122, BIRT-HOGG-DUBÉ SYNDROME","phenotypePositiveAllelePositive":6,"phenotypes":["obo:HP_0009726","obo:HP_0030436","obo:HP_0002108"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/5b040d71-09ec-49f8-ae5c-1da82ac0638b"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/fa2cddd1-0b56-4e94-86b6-91364f42f665_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12204536","rdfs:label":"Family 202","estimatedLodScore":2.11,"family":{"id":"https://genegraph.clinicalgenome.org/r/fa2cddd1-0b56-4e94-86b6-91364f42f665","type":"Family","rdfs:label":"Family 202","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"},"member":{"id":"https://genegraph.clinicalgenome.org/r/79da4c79-3e8a-4812-87ea-cf1ad58ea149"}},"meetsInclusionCriteria":true,"phenotypeFreeText":"ORPHA:122, BIRT-HOGG-DUBÉ SYNDROME","phenotypePositiveAllelePositive":7,"phenotypes":["obo:HP_0030436","obo:HP_0002108","obo:HP_0009726"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/79da4c79-3e8a-4812-87ea-cf1ad58ea149"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/06e963e5-9a0c-4c06-95c8-f493fa8b497a_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12204536","rdfs:label":"Family 230","estimatedLodScore":1.81,"family":{"id":"https://genegraph.clinicalgenome.org/r/06e963e5-9a0c-4c06-95c8-f493fa8b497a","type":"Family","rdfs:label":"Family 230","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"},"member":{"id":"https://genegraph.clinicalgenome.org/r/dbc07d06-bb44-4cfa-a57b-80f8f54bd7af"}},"meetsInclusionCriteria":true,"phenotypeFreeText":"ORPHA:122, BIRT-HOGG-DUBÉ SYNDROME","phenotypePositiveAllelePositive":6,"phenotypes":["obo:HP_0030436","obo:HP_0002108","obo:HP_0009726"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/dbc07d06-bb44-4cfa-a57b-80f8f54bd7af"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/36c93f6e-9a2e-47e1-ba81-047cdd0ff032_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12204536","rdfs:label":"Family 201","family":{"id":"https://genegraph.clinicalgenome.org/r/36c93f6e-9a2e-47e1-ba81-047cdd0ff032","type":"Family","rdfs:label":"Family 201","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"},"member":{"id":"https://genegraph.clinicalgenome.org/r/a54b6a52-c581-461e-898d-b81f090309fe"}},"phenotypeFreeText":"ORPHA:122, BIRT-HOGG-DUBÉ SYNDROME","phenotypePositiveAllelePositive":1,"phenotypes":["obo:HP_0030436","obo:HP_0002108","obo:HP_0009726"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/a54b6a52-c581-461e-898d-b81f090309fe"}},{"id":"https://genegraph.clinicalgenome.org/r/c366c423-5d8f-404f-862a-891571fb75d4_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12204536","rdfs:label":"Family 210","family":{"id":"https://genegraph.clinicalgenome.org/r/c366c423-5d8f-404f-862a-891571fb75d4","type":"Family","rdfs:label":"Family 210","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"},"member":{"id":"https://genegraph.clinicalgenome.org/r/7057e09e-6c7b-4cb6-80b1-6c29d5821058"}},"phenotypeFreeText":"ORPHA:122, BIRT-HOGG-DUBÉ SYNDROME","phenotypePositiveAllelePositive":1,"phenotypes":["obo:HP_0002108","obo:HP_0009726","obo:HP_0030436"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/7057e09e-6c7b-4cb6-80b1-6c29d5821058"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12},{"id":"https://genegraph.clinicalgenome.org/r/c96620e8-f9c9-41a0-a979-31fb9928abb6_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c96620e8-f9c9-41a0-a979-31fb9928abb6_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c405d65c-73c6-412b-b767-ff8eb4b53d9b","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a5799d73-09e8-4605-b625-00e2f838ea3e","type":"Finding","dc:description":"LOH and expression of the Bhd gene in Nihon rat RCs (Figure 2). An intragenic Bhd mutation found in an LOH-negative primary RC (T2 in Fig. 2A) in the Nihon rat. (Figure 4).","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14769940","rdfs:label":"BHD gene in Nihon rat model of inherited renal cancer","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/34297a61-1994-40e8-8c2d-42b1fc9d2b39","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f8db0740-ac86-4362-8e20-e6ddb30daeb0","type":"Finding","dc:description":"Flcn+/- mice display preneoplastic kidney lesions and tumors (Figure 1 and Table 2). Increase in proliferation contributes to renal cystogenesis (Figure 3).","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19843504","rdfs:label":"Flcn+/-mice display preneoplastic kidney lesions and tumours","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/fc362e98-5fa5-4d59-868c-fb629151210d","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/990c28cc-4334-4670-bfcb-cd1de948d5f6","type":"Finding","dc:description":"Knockdown of FLCN in ACHN cells led to the formation of significantly larger tumours (Figure 4C, left panel; p<0.05, t test).","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19843504","rdfs:label":"FLCN acts as a general tumour suppressor in human RCC cells","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityCellCultureModelOrganismCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/bc488d50-905a-47b1-950a-179c39d6bd64","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/74447db2-082a-4720-94ee-5787c247f8b2","type":"Finding","dc:description":"Reintroduction of FLCN in 786-0 cells led to a strong decrease in tumour growth (figure 4C, right panel; p<0.01, t test).","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19843504","rdfs:label":"Reintroduction of FLCN in 786-0 cells decreases tumor growth","demonstrates":{"id":"cg:PhenotypeRescue"}}],"specifiedBy":"GeneValidityCellCultureRescueCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":4},{"id":"https://genegraph.clinicalgenome.org/r/c96620e8-f9c9-41a0-a979-31fb9928abb6_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6ca613f2-5136-4f2b-a8c3-15251aac376c","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7b65f719-e03e-4b15-9387-0cdb6c9633e5","type":"Finding","dc:description":"FLCN acts as a general tumour suppressor in human RCC cells in vivo","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19843504","rdfs:label":"FLCN acts as a general tumour suppressor in human RCC cells","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/10c10274-9cff-4b99-8fa4-d63e635a5303","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/48a8d986-90a2-4c26-afc4-238c2a1832f9","type":"Finding","dc:description":"Northern blot analysis revealed a 3.8 kb transcript in most normal adult tissues, including skin, lung, and kidney (Figure 4A) and in fetal lung, kidney, liver, and brain tissue (data not shown).","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12204536","rdfs:label":"RNA tissue expression of BHD","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":5}],"evidenceStrength":"Definitive","sequence":181,"specifiedBy":"GeneValidityCriteria6","strengthScore":17,"subject":{"id":"https://genegraph.clinicalgenome.org/r/YhC-qBRrbJw","type":"GeneValidityProposition","disease":"obo:MONDO_0007607","gene":"hgnc:27310","modeOfInheritance":"obo:HP_0000006"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_c96620e8-f9c9-41a0-a979-31fb9928abb6-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}